PosterPitches

PP1.01 Tjerk Aukema Clinical Cost Analysis between Transcutaneous and Percutaneous Bone Conduction Devices 14:15 – 15:00 CET
PP1.02 Maria Åberg Håkansson Intra- and post-operative experiences from 51 surgeries of a new active transcutaneous bone-anchored implant system. 14:15 – 15:00 CET
PP1.03 Sanja Spiric Important factors for the outcomes of cochlear implantation in children 14:15 – 15:00 CET
PP1.04 Froukje Cals AC102 – Phase I Results and Phase II Initiation for a New Drug Candidate for the Treatment of Sudden Sensorineural Hearing Loss 14:15 – 15:00 CET
PP1.05 Åsa Bonnard Long-term hearing results for otosclerosis patients receiving cochlear implants – Impact of facial nerve stimulation 14:15 – 15:00 CET
PP1.06 Jona Minette Ligon Advancing Surgical Education and Skill Aquisition with the Exoscope for Cochlear Implantation in a Tertiary Hospital 14:15 – 15:00 CET
PP1.07 Georg Schweizer Long-term Results of Reverse Fixation Clip Technique on Electrode Migration Rates in a Large Cochlear Implant Cohort 14:15 – 15:00 CET
PP1.08 Ernst Dalhoff Audiological performance of the hearing contact lens Vibrosonic® alpha 14:15 – 15:00 CET
PP1.09 Harry Powell A prospective multicentre European study investigating a one-step drill system (MONO) for bone anchored hearing procedures – Experience and outcomes at 1 year. 14:15 – 15:00 CET
PP1.10 Ahmad Saeed ATOH-1 Gene Therapy for Regenerating Hair Cells and Restoring Auditory Function in Mice with Acquired Sensorineural Hearing Loss: A Meta Analysis and Bioinformatic Analysis of Preclinical Studies 14:15 – 15:00 CET
PP2.01 Zhengcai Lou Comparison of endoscopic cartilage myringoplasty with and without trimming perforation margins and epithelium of malleus handle for repairing subtotal perforation 15:30 – 16:15 CET
PP2.02 Zhengcai Lou Comparison of long-term outcome of two endoscopic transtympanic myringoplasty for repairing large chronic perforations 15:30 – 16:15 CET
PP2.03 Hedwig M Velde Exome variant prioritization in a large cohort of hearing-impaired individuals indicates IKZF2 to be associated with hearing loss and guides future research for unsolved cases 15:30 – 16:15 CET
PP2.04 Jeremy Wales Progressive loss of sensitivity to electrical stimulation after cochlear implantation in X-linked POU3F4 incomplete partition 3 inner ear malformation deafness 15:30 – 16:15 CET
PP2.05 Sekhar Bandyopadhyay NOTCHED CARTILAGE WITH INCUS INTERPOSITION OSSICULOPLASTY COMBINED WITH CAVITY OBLITERATION – A NOVEL APPROACH : STUDY OF  50 CASES. 15:30 – 16:15 CET
PP2.06 Johan Frijns Neuroanatomical anomalies associated with the LAMM syndrome: Implications for ABI placement 15:30 – 16:15 CET
PP2.07 Froukje Cals Postoperative surgical site infection in cholesteatoma surgery with and without mastoid obliteration, what can we learn? 15:30 – 16:15 CET
PP2.08 Bob Lerut En Hamac tympanoplasty and canalplasty for optimal type 1 tympanoplasty outcomes 15:30 – 16:15 CET
PP2.09 Kanu Saha External Auditory Canal Cholesteatoma: Clinical Presentation and Management of 22 cases 15:30 – 16:15 CET
PP2.10 Chloe Swords Otopathology of Incomplete Partition Type III: Implications for Cochlear Implantation 15:30 – 16:15 CET
PP2.11 Yibo Zhang A novel classification system and surgical strategies of first branchial cleft anomalies 15:30 – 16:15 CET
PP3.01 Cuneyt M. Alper Success in Valsalva maneuver in each ear may vary in a patient due to differences in peri-luminal tissue pressures between the Eustachian tubes. 16:15 – 17:00 CET
PP3.02 Raymond Van De Berg The vestibular implant: Results of the second generation device 16:15 – 17:00 CET
PP3.03 Yu Si A Multicenter, Single-arm, Objective Performance Criteria-controlled Clinical Study of the Safety and Efficacy of the Double-lumen Eustachian Tube Balloon Catheter 16:15 – 17:00 CET
PP3.04 Yu Si Targeted temporal bone CT guidance for intratympanic steroid therapy 16:15 – 17:00 CET
PP3.05 Christoph J. Pfeiffer MRI-related artifacts after implantation of passive titanium implants and their influence on the detectability of cholesteatoma 16:15 – 17:00 CET
PP3.06 Ingo Todt First clinical experience with a new device for the removal of cochlear schwannoma 16:15 – 17:00 CET
PP3.07 Thijs Van Hees High-quality educational surgery videos 16:15 – 17:00 CET
PP3.08 Ali Eftekharian CSF gusher in cochlear implantation; our experience with 30 cases 16:15 – 17:00 CET
PP3.09 Thadé Goderie Treatment response evaluation in necrotizing otitis externa using FDG-PET imaging 16:15 – 17:00 CET
PP3.10 Simon Kasper Treatment of sinus thrombosis secondary to mastoiditis. 16:15 – 17:00 CET
PP3.11 Olaf Neve Automated measurement of vestibular schwannoma on MRI 16:15 – 17:00 CET
PP3.12 Kimberley S Koetsier The course of hearing loss in patients with a progressive vestibular schwannoma 16:15 – 17:00 CET